Karolinska Development AB

Karolinska Development AB

Karolinska Development AB

Overview
Date Founded

2006

Headquarters

Tomtebodavägen 23A,Solna, Stockholm 171 65

Type of Company

Public

Employees (Worldwide)

13

Industries

Pharmaceuticals

Company Description

Karolinska Development AB engages in the investment in pharmaceutical and medical technology companies. Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The company was founded in 2006 and is headquartered in Solna, Sweden.

Contact Data
Trying to get in touch with decision makers at Karolinska Development AB? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Director

Deputy Chief Executive Officer

Chief Scientific Officer

Head of Accounting

Controller

Director

Director

Chief Financial Officer & Investment Director

Board of Directors

Executive Chairman at Isogenica Ltd.

Founder at Sino Biopharmaceutical Ltd.

Vice Chairman at Beijing Tide Pharmaceutical Co., Ltd.

Director at Essity AB

Director at Dedicare AB

Director & Vice President-Business Development at Pharmathen International SA

Director at Karolinska Development AB

Paths to Karolinska Development AB
Potential Connections via
Relationship Science
You
Karolinska Development AB
Owners & Shareholders
Details Hidden

Östersjöstiftelsen is a Swedish company located in Huddinge and ultimately controlled by the Government of Sweden. The firm provides investment advice for Foundations.

Details Hidden

Part of Karolinska Institutet, Karolinska Institutet Holding AB is a Swedish company located in Stockholm that provides investment advice for foundations. Folke Meijer is currently the CEO of the firm.

Details Hidden

Östersjöstiftelsen is a Swedish company located in Huddinge and ultimately controlled by the Government of Sweden. The firm provides investment advice for Foundations.

Recent Transactions
Details Hidden

BioArctic AB issued SEK Ordinary Shares

Details Hidden

Athera Biotechnologies AB /Private Group purchases Athera Biotechnologies AB from European Investment Fund, Karolinska Development AB

Details Hidden

Inhalation Sciences Sweden AB/ Private Group purchases Inhalation Sciences Sweden AB from Karolinska Development AB

Transaction Clients

Advised on BioArctic AB issued SEK Ordinary Shares

Transaction Advisors
Underwriter

Advised onKarolinska Development AB issued SEK Ordinary Shares

Underwriter

Advised onKarolinska Development AB issued SEK Ordinary Shares

Underwriter

Advised onKarolinska Development AB issued SEK Ordinary Shares

Advisors & Consultants
Advisor

Executive Chairman at ReWind Therapeutics NV

Consultant

Chief Executive Officer & Managing Director at Allecra Therapeutics GmbH

Legal Advisor

Partner at Roschier, Attorneys Ltd.

Key Stats and Financials As of 2020
Market Capitalization
$32.8M
Total Enterprise Value
$33.2M
Earnings Per Share
$-0.13
TEVNet Income
-1.5x
Enterprise Value / Sales
117.16x
Three Year Compounded Annual Growth Rate Of Revenue
-63.06%
Debt TEV
0.23x
EBITDAMargin
-7,609.81%
Revenue
$283K
Net Profit
$-22.2M
Total Debt
$7.55M
Total Equity
$85.5M
EBITDA
$-21.6M
Investors
Details Hidden

Former Secretary & General Counsel at Karolinska Development AB

Suppliers
Generic Sweden AB Other Business & Consulting Services | Stockholm, Sweden

Generic Sweden AB operates as a technology company, which provides messaging services for all applications. It offers a platform for digital communication services that can be integrated into customer's internal or external communication flow. The services are provided through a Communication Platform as a Service (CPaaS) model. The company was founded in 1993 and is headquartered in Stockholm, Sweden.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Karolinska Development AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Karolinska Development AB's profile does not indicate a business or promotional relationship of any kind between RelSci and Karolinska Development AB.